THRN — Thorne HealthTech Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMid Cap
- $550.63m
- $563.26m
- $228.73m
Annual cashflow statement for Thorne HealthTech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -18.2 | -3.95 | 6.84 | 14.9 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 18.5 | 19 | 14 | 12.9 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -12.5 | -2.26 | -16.2 | -20.7 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -7.62 | 17.1 | 9.08 | 5.22 |
| Capital Expenditures | -2.9 | -2.32 | -5.06 | -17.9 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -1.29 | -1.37 | -2.12 | -15.8 |
| Acquisition of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -4.19 | -3.69 | -7.18 | -33.6 |
| Financing Cash Flow Items | — | — | -10 | 2.5 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 11.7 | 1.38 | 38.8 | 13.4 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.124 | 14.8 | 40.7 | -15.1 |